In continuation to letter No. JPL/CS/2126/2024 dated 23rd September, 2024, Jenburkt Pharmaceuticals has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 05th November, 2024, at the Registered Office of the Company, to take on record the unaudited financial results for the quarter and half year ended on 30th September, 2024.
The above information is a part of company’s filings submitted to BSE.